Christopher Garris

7.6k citations
33 papers · 3.4k · 4 hit papers · h-index 20

Impact in

  • Immunology top 1%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Phagocytosis and Immune Regulation
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immune cells in cancer 17
    • Immunotherapy and Immune Responses 11
    • Immune Cell Function and Interaction 10
    • Cancer Immunotherapy and Biomarkers 7
    • CAR-T cell therapy research 3

Christopher Garris

33 papers receiving 3.4k citations

Christopher Garris's Hit Papers

A neutrophil response linked to tumor control in immunotherapy 2023 · 250 citations
2500+3+6Years since publication250500750

Peers

Christopher Garris
Comparison fields: 5 of 103
  • Immunology 2.0k
  • Oncology 1.0k
  • Cancer Research 269
  • Biomaterials 234
  • Biomedical Engineering 769
Replace Christina Pfirschke with:
Christina Pfirschke United States
Sean P. Arlauckas United States
Carola H. Ries Germany
Alex D. Waldman United States
Yoko Oei United States
Viviana Cremasco United States
Steven De Vleeschouwer Belgium
Vincent Chan United States
Laura Conti Italy
Per Øyvind Enger Norway
Christopher Garris relative to Christina Pfirschke United States Christina Pfirschke's profile →
Citations per field
00.5×1.5×
Christina Pfirschke · 1×
Citations per year

Countries citing papers authored by Christopher Garris

Since Specialization
Citations

This map shows the geographic impact of Christopher Garris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Garris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Garris more than expected).

Fields of papers citing papers by Christopher Garris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Garris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Garris. The network helps show where Christopher Garris may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Garris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Garris Line = papers co-authored together Christopher Garris links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Hit paper breakdown →
2018889
2
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
Hit paper breakdown →
2017511
3 2016262
4
A neutrophil response linked to tumor control in immunotherapy
Hit paper breakdown →
2023250
5
Dendritic cells as shepherds of T cell immunity in cancer
Hit paper breakdown →
2023171
6 2017146
7 2013133
8 2012123
9 2014117
10 2020106
11 201996
12 201683
13 201978
14 202167
15 202152
16 202451
17 201850
18 200949
19 202233
20 201924

About Christopher Garris

Christopher Garris is a scholar working on Immunology, Oncology, Molecular Biology, Biomedical Engineering and Genetics, having authored 33 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immune cells in cancer (17 papers), Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (4 papers), CAR-T cell therapy research (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (1.0k citations), Cancer Research (269 citations), Biomaterials (234 citations) and Biomedical Engineering (769 citations). Christopher Garris has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Mikaël J. Pittet, Ralph Weissleder, Michael F. Cuccarese, Sean P. Arlauckas, Rainer H. Köhler, Christopher B. Rodell, Maaz S. Ahmed, Ran Li, Miles A. Miller and Thorsten R. Mempel. Their work appears in journals such as Advanced Science, Nature Immunology, Science Translational Medicine, Theranostics and Nature Biomedical Engineering.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact